医学
碘化油
索拉非尼
肝细胞癌
阿霉素
阶段(地层学)
临床终点
胃肠病学
内科学
随机化
随机对照试验
外科
化疗
古生物学
生物
作者
Wenzhe Fan,Bowen Zhu,Shuling Chen,Yanqin Wu,Xiao Zhao,Liangliang Qiao,Zhen Huang,Rong Tang,Jinghua Chen,Wan Yee Lau,Minshan Chen,Jiaping Li,Ming Kuang,Zhenwei Peng
出处
期刊:JAMA Oncology
[American Medical Association]
日期:2024-08-01
卷期号:10 (8): 1047-1047
被引量:1
标识
DOI:10.1001/jamaoncol.2024.1831
摘要
Transarterial chemoembolization (TACE) is commonly used to treat patients with recurrent intermediate-stage hepatocellular carcinoma (HCC) and positive microvascular invasion (MVI); however, TACE alone has demonstrated unsatisfactory survival benefits. A previous retrospective study suggested that TACE plus sorafenib (SOR-TACE) may be a better therapeutic option compared with TACE alone.
科研通智能强力驱动
Strongly Powered by AbleSci AI